Simponi

golimumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for Simponi, covering 2009-04-24 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study [Phase 2]